Twin Securities’s Cidara Therapeutics CDTX Stock Holding History

Twin Securities’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,900	Closed	-$1.08M	–	18
2025 Q4	$1.08M	Buy	+4,900	New	+$792K	0.41%	13

Twin Securities's CDTX Position: Q1 2026 in Review

Twin Securities sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 4,900 shares — an estimated $1.08M sold.

Twin Securities first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.08M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Twin Securities reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Twin Securities sold 4,900 Cidara Therapeutics shares in Q1 2026, an estimated $1.08M.
Twin Securities first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Twin Securities's Cidara Therapeutics position peaked at $1.08M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Twin Securities's 13F filing for Q1 2026, filed 15 May 2026.